Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory RENSSELAER, N.Y., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, launched Cage+, a holistic, innovative approach to murine...

Taconic Biosciences Launches TruIMPORT™ Importation Solution RENSSELAER, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen...

Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio RENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random...

Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences RENSSELAER, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences’ Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective...

Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated...